Dataset evaluating the treatment timeliness of cervical cancer in Zambia

LATEST ARTICLES
SEARCH INDEX
SUGGEST ARTICLE
THE OSI COLLECTIONS
AUDIOGRAM SERIES
ABOUT THE OSI
2020 SUMMARY

OSI STATISTICS

Open access articles:
1129
Annotations added:
3
Countries represented:
112
No. of contributors:
13
Bookmarks made:
22

Dataset evaluating the treatment timeliness of cervical cancer in Zambia


JournalData in Brief
Article typeJournal research article – Clinical research
Publication date – Jun – 2021
Authors – Jane Mwamba Mumba, Lackson Kasonka , Okola Basil Owiti , John Andrew , Mwansa Ketty Lubeya, Lufunda Lukama , Charlotte Kasempa, Susan C. Msadabwe , Chester Kalinda
Keywordscervical cancer, Public health facility, screening, Turnaround time
Open access – Yes
SpecialityHealth policy, Obstetrics and Gynaecology, Surgical oncology
World region Southern Africa
Country: Zambia
Language – English
Submitted to the One Surgery Index on June 21, 2021 at 10:56 pm
Abstract:

Cervical cancer is the fourth most common cancer diagnosed among women globally. Effective screening routines and early detection are vital in reducing its disease burden and mortality. Several factors can influence the timely detection and treatment of cervical cancer, especially in low middle-income countries where the burden of this disease is highest. The data presented in this paper relates to the research article “Cervical cancer diagnosis and treatment delays in the developing world: Evidence from a hospital-based study in Zambia”. The raw and analysed data include the studied patients’ social demographic factors, clinical data concerning the stage and histological subtype of cancer, dates at which the various activities within the cancer treatment pathway occurred and delays to definitive treatment of cervical cancer at Zambia’s only cancer treatment facility. Detailing delays to the treatment of cervical cancer allows recognition of specific points in the cancer treatment pathway requiring intervention to effectively improve cancer care and reduce the morbidity and mortality associated with the disease.

OSI Number – 21137

Public annotations on this article:
No public annotations yet